
• Platelet Aggregation
• Platelet Inhibition
• Platelet Count
• CBC
By directly monitoring the platelet's ability to form an aggregate, it's a direct measurement of the platelet's ability to contribute to a thrombus. Plateletworks can be used to monitor all mechanisms which effect platelet aggregation:
• Physiological conditions such as fibrinolytic damage to glycoprotein la
• Aspirin and ADP inhibitors (clopidogrel, ticlopene)
• Antifibrinolytics
• Glycoprotein IIb/IIIa inhibitors (abciximab, eptifibatide, tirofiban)
• New Arachadonic Acid agonist is the only screening assay suitable for patients on both clopidogrel and aspirin

Plateletworks is a simple, yet effective procedure.
• Efficient pre-surgical screen
• Monitor anti-platelet therapies
• Determine best use of transfusion resources
• Uses traditional agonists
• No specialized training or equipment
• Use whole blood at the point of care
| Cat. No. | Item | |
| 5860 | Plateletworks ADP Kit | |
| 5862 | Plateletworks Collagen Kit | |
| 5864 | Plateletworks Arachidonic Acid Kit* | |
| 5850 | Plateletworks Combo-15 Kit | |
| 5852 | Plateletworks Combo-25 Kit | |
| 5854 | Plateletworks Combo-10 Kit |
![]() |
|||||||||||
|
|
|
|
|||||||||
|
|
|
|
|
|
|
||||||
|
|
![]() |
|
|||||||||
![]() |
|
||||||||||
![]() |
![]() |
||||||||||
![]() |
![]() |
||||||||||
|
|
![]() |
![]() |
![]() |
||||||||
![]() |
|||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|